Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections
Maura Iversen
Part of the Life Sciences Commons
Works by M. Iversen in Life Sciences
2015
2013
WS1.5 First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients
Maura Iversen
Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies
Maura Iversen
The Time Course of Development and Impact From Viral Resistance Against Ganciclovir in Cytomegalovirus Infection
Maura Iversen
2011
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237
Maura Iversen
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
Maura Iversen
2010
2009
Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation.
Maura Iversen
2008
530: Microarray Based Measurement of Autoantibodies Identifies Early Development of BOS in Lung Transplant Patients
Maura Iversen
2007
Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Maura Iversen
2005
A comparison between antithymocyte globulin and dacluzimab induction therapy for lung transplantation. A retrospective analysis of the frequency of acute cellular rejection in 270 patients
Maura Iversen